Adverse event rates following primary PCI for STEMI at US and non-US hospitals: three-year analysis from the HORIZONS-AMI trial-Reference-Cited by-同舟云学术

Adverse event rates following primary PCI for STEMI at US and non-US hospitals: three-year analysis from the HORIZONS-AMI trial

Published:2013-02 Issue:10 Volume:8 Page:1134-1142
ISSN:1774-024X
Container-title:EuroIntervention
language:
Short-container-title:EuroIntervention

Author:

Tobbia Patrick,Brodie Bruce,Witzenbichler Bernhard,Metzger Chris,Guagliumi Giulio,Yu Jennifer,Kellett Mirle A.,Stuckey Thomas,Fahy Martin,Mehran Roxana,Stone Gregg W.

Publisher

Europa Digital & Publishing

Subject

Cardiology and Cardiovascular Medicine

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of two-year survival rate after acute myocardial infarction in patients with impaired carbohydrate metabolism during novel coronavirus infection pandemic;Perm Medical Journal;2024-01-22

2. Relationship between adiponectin and copeptin levels with long-term cardiovascular mortality in ST-segment elevation myocardial infarction after percutaneous coronary intervention;CARDIOVASC J AFR;2023

3. The efficacy of sodium ferulate combination therapy in coronary heart disease: A systematic review and meta-analysis;Phytomedicine;2023-07

4. The impact of high on-treatment platelet reactivity and fibrinogen levels on ischemic events in patients with ST elevation myocardial infarction: a prospective observational study;International Journal of Clinical Pharmacy;2023-01-13

5. The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial;Circulation;2022-12-06